The effects of phosphorylation on the functional regulation of an expressed recombinant human dopamine transporter

Neuroscience Letters

Volumn 216, Issue 2, 1996, Pages 133-136

  Vrindavanam, N S ^a   Arnaud, P ^a   Ma, J X ^b   Altman Hamamdzic, S ^a   Parratto, N P ^a   Sallee, F R ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Binding; Dopamine transporter; Functional regulation; Metabolic labeling; Phosphorylation; Uptake

Indexed keywords

DOPAMINE TRANSPORTER; FORSKOLIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOG; DOPAMINE UPTAKE; GENETIC TRANSFECTION; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; KIDNEY CELL; MONKEY; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

EID: 0030604010     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/0304-3940(96)13034-2     Document Type: Article

References (17)

1. [1] Amara, S.G. and Kuhar, M.J., Neurotransmitter transporters: recent progress, Annu. Rev. Neurosci., 16 (1993) 73-93.
2. [2] Axelrod, J., The metabolism, storage and release of catecholamines, Rec. Prog. Horm. Res., 21 (1965) 597-619.
3. [3] Cass, W.A., Larson, G., Fitzpatrick, F.A. and Zahniser, N.R., Inhibitors of arachidonic acid metabolism: effects on rat striatal dopamine release and uptake, J. Pharmacol. Exp. Ther., 257 (1991) 990-996.
4. [4] Copeland, B.J., Neff, N.F. and Hadjiconstantinou, M., Protein kinase C activators decrease dopamine uptake into striatal synaptosomes, Soc. Neurosci. Abstr., 21 (1995) 1381.
5. [5] Giros, B., Jaber, M., Jones, S.R., Wightman, R.M. and Caron, M.G., Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter, Nature, 379 (1996) 606-612.
6. [6] Giros, B., El Mestikawy, S., Bertrand, L. and Caron, M., Cloning and functional characterization of a cocaine-sensitive dopamine transporters, FEBS Lett., 295 (1991) 149-154.
7. [7] Giros, B., El Mestikawy, S., Godinot, N., Zheng, K., Han, H., Yang-Feng, T. and Caron, M.G., Cloning, pharmacological characterization, and chromosome assignment of the human dopamine transporter, Pharmacology, 42 (1992) 383-390.
8. [8] Horn, A.S., Dopamine uptake: a review of progress in the last decade, Neurobiology, 34 (1990) 387-400.
9. [9] Huff, R.A., Vaughan, R.A., Kuhar, M.J. and Uhl, G., Protein kinase activity modulates dopamine transporter function, Soc. Neurosci. Abstr., 21 (1995) 1380.
10. [10] Javitch, J.A., D'Amato, R.J., Strittmatter, S.M. and Snyder, S., Parkinsonism-inducing neurotoxin. N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity, Proc. Natl. Acad. Sci. USA, 82 (1985) 2173-2177.
11. [11] Kadowaki, K., Hirota, K., Koike, K., Ohmiche, M., Kiyama, H., Miyake, A. and Tanizawa, O., Adenosine 3′5′-cyclic monophosphate enhances dopamine accumulation in rat hypothalamic cell culture containing dopaminergic neurons, Neuroendocrinology, 52 (1990) 256-261.
12. [12] Kitayama, S., Dohi, T. and Uhl, G.R., Phorbol esters alter functions of the expressed dopamine transporter, Eur. J. Pharmacol., 168 (1994) 115-119.
13. [13] Pristupa, B.Z., Wilson, M.J., Hoffman, J.B., Kish, J.S. and Niznik, B.H., Pharmacological heterogeneity of the cloned and native human dopamine transporter: disassociation of [3H]WIN 35,428 and [3H]GBR 12,935 binding, Mol. Pharmacol., 45 (1994) 125-135.
14. [14] Shimada, S., Kitayama, S., Lin, C.-L., Patel, A., Nanthakumar, E., Gregor, P., Kuhar, M. and Uhl, G., Cloning and expression of a cocaine-sensitive dopamine transporter complementary DNA, Science., 254 (1991) 576-578.
15. [15] Sitges, M., Reyes, A. and Chiu, L.M.J., Dopamine transporter mediated release of dopamine role of chloride, J. Neurosci. Res., 39 (1994) 11-22.
16. [16] Tian, Y., Kapatos, G., Granneman, J.G. and Brannon, M.J., Dopamine and γ-aminobutyric acid transporters: differential regulation by agents that promote phosphorylation, Neurosci. Lett., 173 (1994) 143-146.
17. [17] Ritz, M.C., Lamb, R.J., Goldberg, S.R. and Kuhar, M.J., Cocaine self administration appears to be mediated by dopamine uptake inhibition, Prog. Neuropsychopharmacol. Biol. Psychiatry, 12 (1988) 233-239.